openPR Logo
Press release

Gene Therapy Market is Expected Highest Growth Due To Government Initiative To Improve Healthcare Infrastructure Which Fuel The Market Growth

03-15-2019 09:47 AM CET | Health & Medicine

Press release from: Allied Market Research

Gene Therapy Market

Gene Therapy Market

Increased awareness of the benefits of using gene therapy versus government support to promote existing therapies and therapies for the treatment of a variety of diseases is a major driver of market growth.

Increased funding for research and development activities related to gene therapy and increased awareness of gene therapy are key drivers of market growth. In addition, increased government support, increased ethical acceptance of gene therapy for cancer treatment, and increased cancer spread can drive growth in the gene therapy market. However, high costs associated with treatment and unwanted immune responses are expected to hamper market growth.

The Global Gene Therapy Market is estimated at $ 584 million in 2016 and is expected to reach $ 442 million by 2023, with a CAGR of 33.3% from 2017 to 2023. North America is the largest contributor to the 2016 gene therapy market. However, the Asia Pacific region is expected to have the highest growth rate during the forecast period.

Download PDF Report Sample @ https://www.alliedmarketresearch.com/request-sample/2841?utm_source=sy-Openpr

The key companies profiled in the report include
• Novartis
• Kite Pharma Inc.
• GlaxoSmithKline PLC
• Spark Therapeutics Inc.
• Bluebird bio Inc.
• Genethon
• Transgene SA
• Applied Genetic Technologies Corporation
• Oxford BioMedica
• NewLink Genetics Corp.

Other prominent players in the value chain include Amgen, Epeius Biotechnologies, Abeona Therapeutics, Sanofi, UniQure, Juno Therapeutics, Adaptimmune, Celgene, and Advantagene.

Make an Enquiry @ https://www.alliedmarketresearch.com/purchase-enquiry/2841?utm_source=sy-Openpr

Among the vector type, viral vectors contribute to the largest share in 2016, and estimated to retain the same trend during the forecast period. Non-viral vector is anticipated to be a lucrative market due to the technological advancement of these vectors with positive results for these therapies during the preclinical and clinical trials for the treatment of various diseases.

Among the gene type, antigen dominates the overall market accounting for two-ninths of the total share in 2016. Among the applications, oncological disorders is the largest contributor towards the market growth.

In 2016, North America accounted for maximum contribution to the total revenue generated, owing to the high prevalence rate of cancer, presence of high disposable income, and high funding for R&D activities associated with gene therapy. However, Asia-Pacific is expected to witness the highest CAGR during the analysis period, attributable to rise in incidence rate of cancer, increase in government initiative to improve healthcare infrastructure, and rise in healthcare expenditure.

Key Findings of the Gene Therapy Market:
• Non-viral vectors is projected to grow at the highest rate during the analysis period.
• Oncological disorders segment generated the highest revenue, and is expected to continue its dominance in future.
• North America dominated global gene therapy market in 2016, and is projected to continue its dominance in future.
• China is expected to grow highest in the Asia-Pacific region during the forecast period.
• Antigen was the largest contributor among the gene type segments.

Access Full Summery @ https://www.alliedmarketresearch.com/gene-therapy-market?utm_source=sy-Openpr

About Us:

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Contact:

David Correa

5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States

Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975

help@alliedmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Gene Therapy Market is Expected Highest Growth Due To Government Initiative To Improve Healthcare Infrastructure Which Fuel The Market Growth here

News-ID: 1656365 • Views: 311

More Releases from Allied Market Research

Cash Logistics Market Statistics, Size Will Hit $30,707.7 Million By 2025 | Grow …
According to the report published by Allied Market Research, the global cash logistics market garnered $16.50 billion in 2017 and is expected to reach $30.70 billion by 2025, registering a CAGR of 7.8% from 2018 to 2025. Access Full Summary @ https://www.alliedmarketresearch.com/cash-logistics-market Growth in circulation of cash, rise in demand for safe and vault for cash management, and increase in deployment of ATMs drive the market growth. The cash-in-transit segment captured
Automotive Tubeless Tire Market Trending Technologies, Developments, Key Players …
The Objective of the “Global Automotive Tubeless Tire Market” report is to depict the trends and upcoming for the Automotive Tubeless Tire industry over the forecast years. Automotive Tubeless Tire Market report data has been gathered from industry specialists/experts. Although the market size of the market is studied and predicted from 2017 to 2023 mulling over 2016 as the base year of the market study. Attentiveness for the market has
Aerospace Robotics Market Worth $5,687 Billion by 2022 | Business Strategies, Te …
Aerospace Robotics Market Report, published by Allied Market Research, projects that the global aerospace robotics market is expected to reach $5,687 million by 2022, growing at a CAGR of 17.2% from 2016 to 2022. The articulated robot segment is expected to dominate the global market during the forecast period. North America is expected to generate the maximum revenue in the global market by 2022. Access Full Summary @ https://www.alliedmarketresearch.com/aerospace-robotics-market The aerospace robotics
Turbocharger Market Share, Generating Revenue Of $24.23 Million By 2027 At a CAG …
op 10 leading companies in the global turbocharger market are analyzed in the report along with their business overview, operations, financial analysis, SWOT profile and turbocharger products and services. The key players operating in the global turbocharger industry include BorgWarner Inc. Continental AG, Cummins Inc., EATON Corporation, Honeywell International Corporation, IHI Corporation, Mitsubishi Heavy Industries, Precision Turbo & Engine, Rotomaster International and Turbo Dynamics Ltd Latest news and industry developments

All 5 Releases


More Releases for Gene

Gene Synthesis Market by Top Manufacturers - Gene script, Gene Art (Thermofische …
The "Gene Synthesis Market" report Added by "Big Market Research", enumerates information about the industry in terms of market share, market size, revenue forecasts, and regional outlook. The report further illustrates competitive insights of key players in the business vertical followed by an overview of their diverse portfolios and growth strategies. In the Gene Synthesis Market 2018 research report professionals describe the different facets of the industry with a specific goal
Gene Therapy Market, by Gene Therapy Type Germline Gene Therapy and Somatic Gene …
Genes are composed of deoxyribonucleic acid (DNA), which contains essential information for producing proteins that are crucial for the optimal functioning of the body. Genetic disorder is the result of gene mutations in which proteins are made incorrectly. Gene therapy is intended to introduce healthy gene into damaged cells to counteract for abnormal genes or to make a protein of interest. Mutated gene causes missing of the important protein, with
Gene Synthesis Market Size 2017-2022 OriGene, Gene Oracle, Genescript
e Global Gene Synthesis Market Research Report 2016 is a professional and in-depth study on the current state of the Gene Synthesis market. Annual estimates and forecasts are provided for the period 2017 through 2022. Also, a six-year historic analysis is provided for these markets. The Global market for Gene Synthesis is expected to reach about 410 million USD by 2022 from 200 million USD in 2017, registering a compounded
Gene Therapy Drug Pipeline Analysis
“Gene Therapy Drug Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various drugs being developed for the treatment of multiple disease based upon Gene Therapy. Research report covers all the ongoing drug development in various development phases. Each drug profiles include detailed information like: Originator, Owner, Collaborator, Technology Provider, Licensee, Development Phase, Development Indications, Mechanism of Action, Country of Development and detailed analysis on the development process. Insight
Cancer Gene Therapy Market Analysis
The gene therapy market has undergone series of transformation from the initial days of research to current clinical development of drugs for treatment of multiple diseases. The initial studies of gene therapy were conducted mostly on monogenetic diseases, but the focus of the researchers rapidly shifted towards the cancer. The increasing popularity of cancer therapeutics as a major interest for gene therapy applications led to it accounting for a dominant
Global Gene Editing Technologies Market
Gene editing with engineered nucleases is anticipated to contribute significantly to the global life sciences industry. Gene editing provides application from studying gene functions in plants and animals to gene therapy in humans. Gene editing has more efficiency than many other methods in reverse genetics. Increased development of genetic engineering and increased funding in the field of gene editing is anticipated to drive the growth of the global gene editing